A case-control study of treatment choices made by doctors diagnosed with early breast cancer

International Journal of Surgery
Rachel L O'ConnellJennifer E Rusby

Abstract

Doctors who are diagnosed with breast cancer form a small subset of women with unique insight into their disease. The aim of this study was to compare key treatment decisions in medically-qualified doctors with equivalent degree-educated, matched controls diagnosed with early breast cancer. Patients diagnosed with breast cancer between 01/01/2006 and 31/12/2011 were included and screened for occupation by 2 independent investigators. Allied health professionals with a medical background (e.g. nurses, physiotherapists) were excluded. Patient controls were matched by age, nodal status and grade. If there were more than 5 possible matches then those patients with the closest tumour size were selected. 5259 of 8623 patients had signed the generic research consent form. 619 of these were either doctors, or had received tertiary level education and could form appropriate controls. After exclusions, 46 medically-qualified doctors and 230 matched control patients were included in the analysis. No statistical differences in age or tumour characteristics were identified between doctors with breast cancer and matched controls. No differences were identified between the two groups in the uptake of mastectomy, chemotherapy, immediate breast...Continue Reading

References

Sep 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·U VeronesiF Rilke
Jul 1, 1997·Medical Decision Making : an International Journal of the Society for Medical Decision Making·R L Street, B Voigt
Feb 27, 2001·Journal of Surgical Oncology·S BenedictP Baron
Oct 26, 2002·BMJ : British Medical Journal·John E Wennberg
Jul 26, 2003·BMJ : British Medical Journal·Ellen M RedinbaughRobert M Arnold
Feb 18, 2004·The Breast : Official Journal of the European Society of Mastology·I SchouR Kåresen
Mar 18, 2004·Journal of the National Cancer Institute·Nancy N BaxterTodd M Tuttle
Feb 9, 2005·British Journal of Cancer·N C HenleyT G Cooke
Jul 1, 2005·Journal of General Internal Medicine·Wendy LevinsonRonald A Thisted
Aug 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven J KatzMonica Morrow
Dec 13, 2006·Patient Education and Counseling·Sarah T HawleySteven J Katz
Jul 10, 2008·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Margaret KayJenny Doust
Sep 17, 2008·The Breast : Official Journal of the European Society of Mastology·Rachel S BallingerLesley Fallowfield
Dec 31, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E Dale CollinsKaren R Sepucha
Sep 2, 2009·Journal of the National Cancer Institute·Sarah T HawleySteven J Katz
Aug 3, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M Rosselli Del TurcoL Cataliotti
Nov 10, 2012·BMJ : British Medical Journal·Albert G MulleyGlyn Elwyn
Mar 26, 2013·The Breast : Official Journal of the European Society of Mastology·R L O'ConnellT Johnson

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.